用于偏头痛的降钙素基因相关肽（CGRP）抑制剂
CGRP Inhibitors for Migraine.
作者信息
Mohanty Diksha, Lippmann Steven
机构信息
Dr. Mohanty is a Neurology Resident Physician, and Dr. Lippmann is a Psychiatry Emeritus Professor at the University of Louisville School of Medicine in Louisville, Kentucky.
出版信息
Innov Clin Neurosci. 2020 Apr 1;17(4-6):39-40.
Abstract
Migraine headaches remain a significant medical concern; lots of people are adversely affected. Many existing pharmacotherapies have disappointing results. The pathophysiology is related to calcitonin gene-related peptide (CGRP) pathways. There is hope for better efficacy from the now-available CGRP inhibitor drugs made available to patients suffering these cephalgias.
摘要
偏头痛仍然是一个重大的医学问题；许多人受到了不利影响。许多现有的药物治疗效果令人失望。其病理生理学与降钙素基因相关肽（CGRP）通路有关。对于患有这些头痛的患者来说，现有的CGRP抑制剂药物有望带来更好的疗效。
相似文献
1
CGRP Inhibitors for Migraine.用于偏头痛的降钙素基因相关肽（CGRP）抑制剂
Innov Clin Neurosci. 2020 Apr 1;17(4-6):39-40.
2
History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.降钙素基因相关肽（CGRP）拮抗剂治疗的历史和综述：从转化研究到治疗。
Headache. 2018 Nov;58 Suppl 3:238-275. doi: 10.1111/head.13379. Epub 2018 Sep 22.
3
Anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018.抗降钙素基因相关肽（CGRP）治疗药物：美国头痛学会第 60 届科学会议（2018 年 6 月，旧金山）后对既往综述的更新。
Headache. 2018 Nov;58 Suppl 3:276-290. doi: 10.1111/head.13417.
4
Role of CGRP in Migraine.降钙素基因相关肽在偏头痛中的作用。
Handb Exp Pharmacol. 2019;255:121-130. doi: 10.1007/164_2018_201.
5
Targeting CGRP for the Prevention of Migraine and Cluster Headache: A Narrative Review.靶向降钙素基因相关肽（CGRP）预防偏头痛和丛集性头痛：一项叙述性综述。
Headache. 2019 Jul;59 Suppl 2:20-32. doi: 10.1111/head.13583.
6
Calcitonin Gene-Related Peptide Antagonists as a Savior in Episodic and Chronic Migraine: A Review.降钙素基因相关肽拮抗剂：发作性和慢性偏头痛的救星——综述
Cureus. 2020 Jun 20;12(6):e8711. doi: 10.7759/cureus.8711.
7
CGRP, a target for preventive therapy in migraine and cluster headache: Systematic review of clinical data.降钙素基因相关肽（CGRP），偏头痛和丛集性头痛预防治疗的靶点：临床数据的系统评价。
Cephalalgia. 2019 Mar;39(3):374-389. doi: 10.1177/0333102417741297. Epub 2017 Nov 7.
8
Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab.降钙素基因相关肽受体作为发作性偏头痛患者治疗的新靶点：erenumab的现有证据及安全性概况
J Pain Res. 2017 Dec 8;10:2751-2760. doi: 10.2147/JPR.S128143. eCollection 2017.
9
The efficacy and safety of calcitonin gene-related peptide monoclonal antibody for episodic migraine: a meta-analysis.降钙素基因相关肽单克隆抗体治疗阵发性偏头痛的疗效和安全性：一项荟萃分析。
Neurol Sci. 2018 Dec;39(12):2097-2106. doi: 10.1007/s10072-018-3547-3. Epub 2018 Sep 4.
10
The Role of Anti-calcitonin Gene-related Peptide in Migraine and its Implication in Developing Countries: A Reasonable Option to Consider Despite Higher Cost.降钙素基因相关肽在偏头痛中的作用及其在发展中国家的意义：尽管成本较高但仍值得考虑的合理选择
Cureus. 2019 Jun 1;11(6):e4796. doi: 10.7759/cureus.4796.
引用本文的文献
1
Pharmacists' Knowledge, Attitudes, and Practices Toward CGRP Inhibitors in Migraine Management: A Cross-Sectional Study.药剂师在偏头痛管理中对降钙素基因相关肽（CGRP）抑制剂的知识、态度和实践：一项横断面研究。
Healthcare (Basel). 2025 Sep 6;13(17):2231. doi: 10.3390/healthcare13172231.
2
Migraine management in Saudi Arabia: An expert consensus.沙特阿拉伯的偏头痛管理：专家共识
Neurosciences (Riyadh). 2025 Jul;30(3):169-176. doi: 10.17712/nsj.2025.3.20240118.
3
A Hybrid Digital-4E Strategy for comorbid migraine and depression: a medical hypothesis on an AI-driven, neuroadaptive, and exposome-aware approach.一种用于偏头痛与抑郁症共病的混合数字-4E策略：关于人工智能驱动、神经适应性和暴露组感知方法的医学假说
Front Neurol. 2025 May 29;16:1587296. doi: 10.3389/fneur.2025.1587296. eCollection 2025.
4
Direct Comparison of Treatment Outcome Between the Botulinum Toxin and Calcitonin Gene-Related Peptide Monoclonal Antibody in Migraine Patients.肉毒杆菌毒素与降钙素基因相关肽单克隆抗体治疗偏头痛患者的疗效直接比较
J Clin Med Res. 2024 Dec;16(11):527-535. doi: 10.14740/jocmr6054. Epub 2024 Nov 30.
5
MetaCGRP is a high-precision meta-model for large-scale identification of CGRP inhibitors using multi-view information.MetaCGRP 是一种高精度的元模型，用于使用多视图信息大规模识别 CGRP 抑制剂。
Sci Rep. 2024 Oct 21;14(1):24764. doi: 10.1038/s41598-024-75487-x.
6
Migraine and Stroke: A Scoping Review.偏头痛与中风：一项范围综述
J Clin Med. 2024 Sep 11;13(18):5380. doi: 10.3390/jcm13185380.
7
Inhibition of Neurogenic Inflammatory Pathways Associated with the Reduction in Discogenic Back Pain.与椎间盘源性背痛减轻相关的神经源性炎症通路的抑制
Asian Spine J. 2023 Dec;17(6):1043-1050. doi: 10.31616/asj.2023.0121. Epub 2023 Dec 5.
8
Zavegepant nasal spray for the acute treatment of migraine: A meta analysis.依帕司他治疗糖尿病周围神经病变有效性和安全性的 Meta 分析。
Medicine (Baltimore). 2023 Oct 27;102(43):e35632. doi: 10.1097/MD.0000000000035632.
9
Self-administration of Psilocybin for the Acute Treatment of Migraine: A Case Report.裸盖菇素自我给药用于偏头痛急性治疗：一例报告
Innov Clin Neurosci. 2023 Sep 1;20(7-9):37-39. eCollection 2023 Jul-Sep.
10
Partners in Pain: New Insights into The Role of CGRP Signaling in Cross-Organ Sensitization.疼痛中的伙伴：对降钙素基因相关肽信号在跨器官致敏作用中的新见解
J Pharmacol Exp Ther. 2023 Oct;387(1):1-3. doi: 10.1124/jpet.123.001770.
本文引用的文献
1
Optimising migraine treatment: from drug-drug interactions to personalized medicine.优化偏头痛治疗：从药物相互作用到个体化医学。
J Headache Pain. 2019 May 17;20(1):56. doi: 10.1186/s10194-019-1010-3.
2
The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse.需要新型急性作用抗偏头痛药物：安全地走出急性药物过度使用。
J Headache Pain. 2019 May 16;20(1):54. doi: 10.1186/s10194-019-1007-y.
3
CGRP and the Trigeminal System in Migraine.降钙素基因相关肽与偏头痛的三叉神经系统。
Headache. 2019 May;59(5):659-681. doi: 10.1111/head.13529. Epub 2019 Apr 14.
4
CGRP Antagonists for the Treatment of Chronic Migraines: a Comprehensive Review.降钙素基因相关肽（CGRP）拮抗剂治疗慢性偏头痛：全面综述。
Curr Pain Headache Rep. 2019 Mar 14;23(5):29. doi: 10.1007/s11916-019-0768-y.
5
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家层面 195 个国家和地区 1990 年至 2017 年 354 种疾病和伤害导致的发病率、患病率和伤残损失寿命年：基于 2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1789-1858. doi: 10.1016/S0140-6736(18)32279-7. Epub 2018 Nov 8.
6
CGRP Monoclonal Antibodies for the Preventative Treatment of Migraine.降钙素基因相关肽单克隆抗体用于偏头痛的预防性治疗。
Curr Pain Headache Rep. 2018 Apr 6;22(5):38. doi: 10.1007/s11916-018-0686-4.
7
The Biology of Monoclonal Antibodies: Focus on Calcitonin Gene-Related Peptide for Prophylactic Migraine Therapy.单克隆抗体的生物学：以降钙素基因相关肽为重点的预防性偏头痛治疗。
Neurotherapeutics. 2018 Apr;15(2):324-335. doi: 10.1007/s13311-018-0622-7.
8
Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.美国偏头痛患者的直接和间接医疗资源利用与成本。
Headache. 2018 May;58(5):700-714. doi: 10.1111/head.13275. Epub 2018 Feb 15.
9
A Controlled Trial of Erenumab for Episodic Migraine.依瑞奈玛单抗治疗发作性偏头痛的对照试验。
N Engl J Med. 2017 Nov 30;377(22):2123-2132. doi: 10.1056/NEJMoa1705848.
10
CGRP - The Next Frontier for Migraine.降钙素基因相关肽——偏头痛治疗的新前沿
N Engl J Med. 2017 Nov 30;377(22):2190-2191. doi: 10.1056/NEJMe1712559.
Zotero 插件